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Transition From Pediatric to Adult Care for Youth
Diagnosed With Type 1 Diabetes in Adolescence
WHAT’S KNOWN ON THIS SUBJECT: Most children with type 1
diabetes get care from pediatric-trained providers, and must
transfer care to adult providers once in adulthood. The timing
of this change in providers and its relationship to glycemic
control is not well understood.
WHAT THIS STUDY ADDS: In this cohort, the estimated median
age to transition to adult care was 20.1 years and 77% had left
pediatric care by age 21. Leaving pediatric care was associated
with a 2.5-fold increase in odds of having poor glycemic control.
abstract
OBJECTIVE: Youth with type 1 diabetes mellitus are at risk for poor
glycemic control as they age into adulthood. The aim of this study was
to describe sociodemographic and clinical correlates of poor glyce-
mic control associated with the transfer of care from pediatric to
adult diabetes providers among a cohort of youth with type 1 diabetes
diagnosed in adolescence.
METHODS: Analyses included 185 adolescent participants with recently
diagnosed type 1 diabetes in the SEARCH for Diabetes in Youth Study
with pediatric care at baseline who were age $18 years at follow-up.
Demographic and clinical factors were measured by survey and
laboratory results. Survival analysis was used to estimate the age
of transition. Logistic regression analysis assessed the association of
demographic and clinical factors with the transition of care and poor
glycemic control at follow-up.
RESULTS: Fifty-seven percent of participants had transitioned to adult
diabetes care providers by the follow-up visit. The estimated median
age of transition of care was 20.1 years (95% confidence interval 19.8–
20.4). Older age, lower baseline glycosylated hemoglobin, and less
parental education were independently associated with increased
odds of transition. The odds of poor glycemic control at follow-up
were 2.5 times higher for participants who transitioned to adult care
compared with those who remained in pediatric care.
CONCLUSIONS: Transferring from pediatric to adult care, experienced
by more than half the sample, was associated with an increased risk of
poor glycemic control at follow-up. These findings suggest that young
adults need additional support when moving to adult care. Pediatrics
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Children and adolescents with type 1
diabetes mellitus will require lifelong
access to medical care and relatively
intensive daily self-management to
maximize adult health outcomes and
health-related quality of life. Most
children with type 1 diabetes are cared
for by pediatric-trained providers (either
endocrinologists or general pediatri-
cians), requiring transfer of care to an
adult-trained provider once they ap-
proach adulthood. Patterns of transfer
vary by location and health care de-
livery system, and are influenced by
local practices and resources, patient/
family preferences, and national poli-
cies.1–3 Although recent work has fo-
cused on understanding access to
care and health outcomes during this
period, these patterns have not been
well described for youth with diabetes
in the United States.1,2,4–6
Glycemic control, critical to long-term
optimal outcomes for diabetes, has
beenshowntobepoor formanyyouthas
they age into adulthood.7–10 Many age-
related factors could contribute to poor
glycemic control, including changes in
biological and psychosocial factors,
and changes in access to care.4,5 More
specifically, the impact of age-related
changes in diabetes care providers on
glycemic control is not well understood.
The longitudinal cohort in the SEARCH
for Diabetes in Youth study (SEARCH)
providesanopportunity to studychanges
in health care providers as youth age
into adulthood. Furthermore, the study
allows us to explore the association
between changes in health care pro-
viders and glycemic control. We hypoth-
esized that older age and female gender
would be associated with greater odds
of transitioning to adult care, and those
changing to adult care would have
worse glycemic control. A more thor-
ough understanding of the transition
period can inform policy and practice
changes to best support youth with
diabetes as they age into adulthood.
METHODS
Study Overview and Procedures
SEARCH is a multicenter study that
began conducting population-based
ascertainment in 2001 among youth
who were ,20 years of age when
diagnosed with diabetes.11 SEARCH
recruited youth from 4 geographically
defined populations in the United
States, Indian Health Service benefi-
ciaries from several American Indian
populations, and enrollees in several
managed health care plans. Institu-
tional review board(s) for each of the
6 study sites approved the study pro-
tocol. All registered participants were
asked to complete a brief initial survey;
survey respondents were invited to a
research visit. During this visit, informed
consent and assent (when applicable)
were obtained, questionnaires were
administered, and physical measure-
ments and fasting blood samples were
obtained from metabolically stable
participants (no episodes of diabetic
ketoacidosis during the previous
month) after a minimum 8-hour over-
night fast. Youth whose diabetes was
diagnosed in 2002 through 2005 were
invited for follow-up visits at approxi-
mately 12, 24, and 60months after their
initial visit.
Study Population
Given our study’s focus on changes in
providers and glycemic control during
the transition to adulthood, we re-
stricted this analysis to youth who
were seen by a pediatric provider at
baseline and had at least 1 follow-up
study visit after reaching age 18 years.
Thus, inclusion criteria were as follows:
SEARCH participants with physician-
diagnosed type 1 diabetes newly di-
agnosed between 2002 through 2005
who were $13 years at their baseline
visit and had at least 1 follow-up visit
after age 18, and who also had a glyco-
sylated hemoglobin (A1c) measurement
at both their baseline and follow-up
visits. Individuals whose first study
visit occurred within the first 3 months
after diagnosis of diabetes were ex-
cluded because of potentially unstable
initial A1c measurement. Only those
who identified their diabetes provider
as pediatric (general pediatric or pedi-
atric endocrinologist) at the baseline
visit were included in our cohort. We
excluded 24 participants who saw adult
providers at baseline, and 61 whose
type of provider at the baseline visit
could not be identified, including those
who reported that their provider was
a physician assistant or nurse, replied
“other/don’t know,” or reported no
provider for diabetes care. We were
unable to identify the type of practices
with which the nurses, nurse practi-
tioners, and physician assistants were
affiliated, which may have been pediat-
ric or adult-trained physicians. An ad-
ditional 27 individuals were excluded
because their type of diabetes provider
at a follow-up visit could not be de-
termined.
When an individual had multiple follow-
up visits, information from the latest
follow-up visit with the longest time
interval from the baseline visit for
which the type of provider could be
identified was used for analysis. An
exception was that all available follow-
up visits were used in the model esti-
mating age at transition as described
later in this article. Figure 1 illustrates




Sociodemographic factors known to be
associated with health care use and
health outcomes in other studies were
selected for inclusion in these analyses.
Race/ethnicity was self-reported, using
the standard 2000 census questions and
categorized as non-Hispanic white, His-
panic, non-Hispanicblack, orother race/
ethnicity; these categories were further
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combined as non-Hispanic white versus
nonwhite participants. Highest parental
education was based on self- or parent-
reported highest parental education.
Health insurance at the time of each
study visit was recorded by participants
as private insurance, Medicaid/Medicare
(including other state-funded sources),
other (including Indian Health Service,
student health clinics, military, or other/
unknown sources), or none; health insur-
ance status was categorized as private
versus nonprivate (combining Medic-
aid, Medicare, or other state-funded
sources, other, or none).
Clinical Characteristics
Medical comorbidities were asthma,
kidney disease, celiac disease, hyper-
tension, orpolycysticovariansyndrome
based on self or parental report. Du-
ration of diabetes was the number of
months elapsed between diagnosis
of diabetes and baseline study visit.
Time between the baseline and follow-
up study visit is recorded in months.
Hemoglobin A1c wasmeasured in whole
blood with an automated nonporous
ion-exchange high-performance liquid
chromatography system (model G-7;
Tosoh Bioscience, Montgomeryville,
PA)byusingbloodsamplesdrawnat the
baseline visit and again at the last
available follow-up visit.
Outcome Variables
“Leaving pediatric care”was defined as
reporting a pediatric diabetes care
provider at the baseline visit and an
adult diabetes care provider at the last
available follow-up visit. Glycemic con-
trol at the follow-up visit was based on
hemoglobin A1c measured at the last
available follow-up visit. “Poor glyce-
mic control” was defined as $9%
based on the Diabetes Control and Com-
plications Trial study documenting risk
for complications among those .18
years old.12 We defined “age at tran-
sition” as occurring between the age
at the last study visit where the par-
ticipant reported a pediatric provider
and the age at the next study visit when
the participant reported an adult pro-
vider, with age estimated using the
methods described as follows.
Statistical Analyses
All analyses were performed with SAS
(version 9.2; SAS Institute, Cary, NC).
Summary statistics were calculated to
describe the sociodemographic and
clinical characteristics for the cohort.
We used separate multivariable logistic
regression models to (1) identify socio-
demographicandclinicalcharacteristics
that were independently associated with
leaving pediatric diabetes care; and (2)
identify predictors of poor glycemic
control at follow-up. Independent vari-
ables included in both multivariable
models were sociodemographic factors
(age at follow-up, race/ethnicity, gender,
type of insurance at follow-up, highest
parental education) and disease-related
factors (diabetes duration, hemoglobin
A1c,presenceofamedicalcomorbidityat
baseline visit). Both models were ad-
justed for SEARCH study site and the time
betweenthebaselineandfollow-upvisits.
The second model included the outcome
variable from the first model as an in-
dicator denoting whether an individual
had transitioned from a pediatric to an
adult diabetes care provider by the
follow-up visit. To assess if the effects of
age and hemoglobin A1c on our out-
comeswere linear (ie, their effect on the
outcome was the same for both low and
higher values of age and A1c) we tested
quadratic terms for age and hemoglobin
A1c. As these terms were both non-
significant, they were excluded from the
final models.
To estimate the ageat transition of care,
we performed a survival analysis by
using all available visits for our cohort.
We used maximum likelihood methods
tofit a lognormal distributionwith right
and interval censored data. Partic-
ipants who had transitioned to adult
carebyanyof their follow-upvisitswere
FIGURE 1
Inclusion criteria for transition of care analysis. DM, diabetes mellitus.
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considered interval censored between
their age at their last pediatric visit and
their age at first transition, whereas
participants who were still in pediatric
care at their last follow-up visit were
considered right censored at their
follow-up age.
RESULTS
Of the 185 youth included in this report,
the average age at diagnosis of diabetes
was 15 years. The baseline visit was∼11
months after diagnosis, when partic-
ipants were, on average, 16 years old
(Table 1). Almost 60% were male, and
76% were non-Hispanic white. The last
follow-up visit took place about 4.5 years
after the baseline visit at an average age
of 20.5 years. Approximately 86% of
individuals had private insurance at
both the baseline and follow-up visits.
Two percent were uninsured at the
baseline visit, which increased to 4% at
follow-up.
Transition From Pediatric Care
Overall, 57%of the samplehadswitched
toanadultdiabetescareproviderby the
last follow-up visit. This proportion in-
creased with increasing age; only 47%
of those aged 18 to 20 years at the last
follow-uphadchanged toadult diabetes
care providers, whereas 77% of those
21 and older had changed. The esti-
mated median age of transition of care
was 20.1 years old (95% confidence
interval (CI) 19.8–20.4).
As depicted in Table 2, in the multiple
logistic regression analysis model
controlling for sociodemographic and
disease-related factors, a 1-year in-
crease in age was associated with
a 1.87 increased odds of leaving pedi-
atric care (95% CI 1.39–2.51, P, .001)
(Table 2). In addition, those with higher
baseline hemoglobin A1c values were
less likely to leave pediatric care; the
odds of leaving pediatric care de-
creased by 27% for every 1-unit in-
crease in A1c (P = .013) after controlling
for age and other confounding factors.
Higher parental education at baseline
(bachelor’s degree or higher) was
significantly associated with reduced
odds of leaving pediatric care, com-
pared with those having less educa-
tion (odds ratio = 0.34, 95% CI 0.14–
0.82).
Poor Metabolic Control at
Follow-Up
Average hemoglobin A1c was 7.5% at
baseline and 9.2% at the follow-up visit.
At baseline, 11% had poor glycemic
control compared with 45% at the
follow-up visit. In the adjusted model,
the odds of having poor glycemic con-
trolat the follow-upvisitwere2.46 times
higher for those who left pediatric care
(95% CI 1.09–5.55, P = .031) than for
those who remained in pediatric care
(Table 3). In addition, nonwhite partic-
ipants had 3.44 times the adjusted
odds of having poor glycemic control at
follow-up compared with non-Hispanic
white participants (95% CI 1.17–10.1,
P = .025). Higher baseline hemoglobin
A1c was also a significant independent
predictor of poor control at follow-up.
For every 1-unit increase in hemoglobin
A1c at baseline, young adults had 1.84
times the odds of having poor control at
follow-up (95% CI 1.38–2.45, P , .001).
DISCUSSION
Recent guidelines from the American
Academy of Pediatrics, the American
College of Physicians, the American
Academy of Family Practice,13 and
the American Diabetes Association3
TABLE 1 Descriptive Characteristics of the Study Population (n = 185)
Characteristics Baseline, n(%) Follow-up, n(%)
Sociodemographic factors
Age in years (mean 6 SD) 15.9 6 1.7 20.5 6 1.5
Male gender 106 (57%) —
Race/Ethnicity
White, non-Hispanic 140 (76%) —
African-American, non-Hispanic 19 (10%) —
Hispanic 18 (10%) —
Other 8 (4%) —
Insurance status
Has private health insurance 158 (86%) 154 (83%)
Medicaid/Medicare/Other 23 (12%) 23(13%)
Uninsured 4 (2%) 8 (4%)
Highest parental education
# High school 33 (18%) —
Some college 47 (26%) —
$ Bachelor’s degree 104 (57%) —
Disease factors
Age at diagnosis, y, mean 6 SD 15.0 6 1.8 —
Diabetes duration at baseline visit, mo, mean 6 SD 11.2 6 6.9 —
Time between visits, mo,a mean 6 SD 55.5 6 16.2
Have a comorbidityb 50 (27%) 56 (30%)
Hemoglobin A1c, %, mean 6 SD 7.49 6 1.74 9.21 6 2.37
Poor glycemic controlc 20 (11%) 84 (45%)
Care factors
Leave pediatrics by last follow-up visitd
Overall 106 (57%)
Age 18–20 at follow-up 58/123 (47%)
Age 21 and over at follow-up 48/62 (77%)
Denominators are sometimes less than 185 because of missing data. —, item not measured at the follow-up visit.
a Time between visits: average time (in months) elapsed between baseline and follow-up visits.
b Have a medical comorbidity: Presence of at least one of the following physician-diagnosed conditions (as reported by study
participants): asthma, polycystic ovarian disease, kidney disease, celiac disease, or hypertension.
c Poor glycemic control: hemoglobin A1c $9.0%
d Leave pediatrics by follow-up: participant reporting that primary diabetes provider is an adult-trained physician at the last
follow-up visit.
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reaffirm that all young adults with di-
abetes should transition to adult-
oriented medical care between 18
and 21 years of age. For our study
population, we estimate that the me-
dian age of transition to adult care is
20.1 years with 77% of young adults
.21 years of age having left pediatric
care. To our knowledge, this is the first
US study to describe the change to
adult care and factors associated with
this transition for a diverse cohort of
adolescents and young adults with type
1 diabetes.
As expected, we found that older age
predicted leaving pediatric care. In
addition,we found that those youthwith
higherhemoglobinA1cat their baseline
visit were less likely to leave pediatric
care. One possible explanation for this
finding is that pediatric providers may
have a higher level of concern for
patients in poor control, and as a result
continue to care for these patients
longer in an attempt to prevent wors-
eningof theirglycemiccontrol. Thismay
include the recognition that such
patients have greater need of psycho-
social resources that may be more
available in the pediatric setting. Our
data also suggest that youth of more
educated parents (bachelor’s degree or
more) are less likely to leave pediatric
TABLE 2 Odds Ratios for Independent Variables Predicting Leaving Pediatric Care and Going to Adult Diabetes Care at Follow-up Visita
Variable Unadjusted Results Adjusted Resultsa
Odds Ratio 95% CI P Value Odds Ratio 95% CI P Value
Sociodemographic factors
Age, y, at follow-up 1.74 1.37–2.23 ,.001 1.87 1.39–2.51 ,.001
Male versus female 0.78 0.43–1.41 .412 0.97 0.47–2.02 .939
Nonwhite versus NH white 1.68 0.83–3.40 .146 1.59 0.52–4.89 .418
Not private versus private insurance at follow-upb 1.22 0.55–2.69 .623 1.39 0.49–3.93 .532
Highest parental education .039 .034
Some college versus # high school 1.35 0.52–3.47 1.10 0.33–3.68 —
$ College graduate versus # high school 0.55 0.25–1.23 0.37 0.12–1.17 —
$ College graduate versus some college 0.41 0.20–0.85 0.34 0.14–0.82 —
Disease factors
Diabetes duration at baseline visit 1.02 0.98–1.07 .319 1.05 0.99–1.11 .136
Have a comorbidity at baselinec 1.47 0.75–2.86 .263 0.92 0.39–2.21 .857
Hemoglobin A1c at baseline 0.85 0.71–1.01 .062 0.73 0.57–0.94 .013
NH, non-Hispanic
a Model controlled for SEARCH study site, time elapsed between baseline and follow-up visits as well as variables presented in the table.
b Not private group consists of n = 23 (74%) publically insured and n = 8 (26%) uninsured.
c Have a comorbidity: presence of at least 1 of the following physician-diagnosed conditions (as reported by study participants): asthma, polycystic ovarian disease, kidney disease, celiac
disease, or hypertension.
TABLE 3 Odds Ratios for Independent Variables Predicting Poor Glycemic Control at Follow-up Visit (Hemoglobin A1c $9%)a
Variable Unadjusted Results Adjusted Results
Odds Ratio 95% Confidence Limits P Value Odds Ratio 95% Confidence Limits P Value
Sociodemographic factors
Age, y, at follow-up 0.79 0.65–0.97 .025 0.77 0.59–1.01 .063
Male versus female 0.63 0.35–1.14 .127 0.70 0.34–1.43 .326
Nonwhite versus NH white 2.18 1.10–4.33 .025 3.44 1.17–10.1 .025
Not private versus private insurance at follow-upb 2.17 0.98–4.78 .055 1.47 0.55–3.88 .443
Highest parental education .897 .352
Some college versus # high school 0.94 0.38–2.28 — 2.04 0.64–6.53 —
$ College graduate versus # high school 0.84 0.38–1.85 — 2.27 0.74–7.01 —
$ College graduate versus some college 0.90 0.45–1.80 — 1.12 0.49–2.56 —
Disease factors
Diabetes duration at baseline visit 1.02 0.98–1.07 .333 0.98 0.93–1.04 .457
Have a comorbidity at baselinec 1.15 0.60–2.21 .666 1.01 0.44–2.29 .991
Hemoglobin A1c at baseline 1.65 1.32–2.07 ,.001 1.84 1.38–2.45 ,.001
Care factors
Leave pediatrics by follow-upd 1.18 0.66–2.12 .577 2.46 1.09–5.55 .031
NH, non-Hispanic.
a Model controlled for SEARCH study site, time elapsed between baseline and follow-up visits as well as variables presented in the table.
b Not private group consists of n = 23 (74%) publically insured and n = 8 (26%) uninsured.
c Have a comorbidity: presence of at least 1 of the following physician-diagnosed conditions (as reported by study participants): asthma, polycystic ovarian disease, kidney disease, celiac
disease, or hypertension.
d Leave pediatrics by follow-up: participant reporting that primary diabetes provider is an adult-trained physician at the follow-up visit.
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care. Future research is needed to ex-
amine the reasons behind these obser-
vations. Other sociodemographic factors
(race/ethnicity, type of insurance), di-
abetes duration, and presence of med-
ical comorbidities, did not affect the
transition to adult care.
We also found that leaving pediatric
care was associated with a 2.5-fold in-
crease in the odds of being in poor
glycemic control at the follow-up visit
compared with those who stay in pe-
diatric care, after controlling for both
sociodemographic and disease-related
factors. Access to care (basedon typeof
health insurance at the follow-up visit
as a proxy measure) did not mediate
the relationship between transition to
adult care and poorer glycemic control.
However, most youth in this cohort
had health insurance as young adults,
and we did not see a difference in
glycemic control between the private
and nonprivately insured groups in
young adulthood. Other evidence that
transition-related problems in adult
care are unrelated to insurance cov-
erage comes from countries with uni-
versal health insurance systems, such
as Canada and Europe. These studies
have found that youth with diabetes
are often not following up in a timely
way with new providers even though
they have access to this care.3,8,9,14–16
These individuals are also at risk for
nonadherence with recommended visit
frequency or disease self-management
tasks, and have more diabetes-related
hospitalizations after leaving pediatric
care.
The finding that individuals from non-
white and Hispanic ethnic/racial back-
grounds had increased risk of poor
control at follow-up, even after con-
trolling for a number of socioeconomic
variables and baseline hemoglobin A1c,
is concerning. Previous research has
suggested that African American and
Hispanic youth are at risk for poor
glycemiccontrolwhile inpediatric care,
although some studies have found that
socioeconomic variables account for
this effect.7,17,18 Young adults from mi-
nority racial/ethnic backgrounds are
considered at increased risk of poor
transition outcomes.19 Given our find-
ings, this warrants further evaluation
in future studies.
Unmeasured factors may account for
the variation in timing of the transfer to
adult care for these youth. Patient fac-
tors, such as psychosocial readiness for
transition, could be influencing pro-
viders’ and families’ willingness to “let
go” and move on to adult care.20 Prac-
tice and environmental factors, such as
the presence of policies around trans-
ferring care in adulthood and/or access
to adult-trained type 1 diabetes spe-
cialists, could also be important.
Further research is urgently needed to
explore reasons why glycemic control
deteriorates in late adolescence and
young adulthood and if alterations in
the timing of transfer from pediatric to
adult care can prevent this outcome.
Young adulthood is a time of multiple
changes, not only in health care needs,
but also physical maturation and
evolving relationships with others. A
better understanding of how life tran-
sitions affect health-related behaviors,
access to health care, and health care
use is needed. More specifically, re-
search focused on examining patient,
parent, and provider attitudes and
behaviors, aswell ashealthcaresystem
processes and obstacles will help to
identify potential causes and inter-
ventions that may mitigate the risk of
deteriorating glycemic control with
transition in this population.
Research is also needed to understand
how providers can best support the
adolescent/young adult population.
Previous studies have shown that phy-
sician continuity and intensive care co-
ordination can help improve patient
transition to adult care.3,21,22 Studies
of various counseling strategies, in-
cluding family-oriented counseling and
youth empowerment strategies, are
also promising.23
LIMITATIONS
We cannot identify participants’ exact
age or hemoglobin A1c value at the time
of transfer to adult care from these data
nor can wemeasure the amount of time
that elapsed between changing pro-
viders and the next follow-up study visit.
In addition, all participants were ado-
lescents who had been recently diag-
nosed with diabetes at the time of study
entry, constraining the observed dura-
tion of illness. Indeed, youth diagnosed
with type 1 diabetes during their teen-
age years may be different from those
who are diagnosed at a younger age
who will have had diabetes for many
years at the time of their transition and
may have had more time to develop
their self-management skills and pre-
pare for transition. In addition, those
more recently diagnosed (even as far
out as 1 year) may have better glycemic
control than those who have had their
disease for longer, perhaps because of
residual islet cell function.7,24 Restrict-
ing our cohort to relatively recently
diagnosed adolescents also likely ex-
plains the difference in the observed
glycemic control in our cohort com-
pared with the SEARCH study partic-
ipants as a whole.7 The interpretation
of the statistically significant relation-
ship between race/ethnicity and gly-
cemic control at follow-up is limited by
the relatively small sample of nonwhite
participants (n = 45, 24% of the cohort)
resulting in a wide confidence interval
for the effect. Despite the limitations,
these analyses are based on a subset
of one of the largest longitudinal co-
horts of youth with type 1 diabetes in
the United States.
CONCLUSIONS
In this cohort of youth who were di-
agnosed with type 1 diabetes during
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their adolescent years, the estimated
median age of transition to adult care is
20.1 yearswith 34% and 18% remaining
in pediatric care on their 21st and 22nd
birthdays, respectively. Leaving pedi-
atric care is associated with poor gly-
cemic control in young adults with type
1 diabetes, independent of previous
poor glycemic control. These findings
suggest that to safely follow current
guidelines, young adults who transi-
tion to adult care require additional
support to maximize their health out-
comes that will extend for some time
beyond the transfer to an adult pro-
vider. Further studies are needed to
understand the factors mediating the
relationship between changing pro-
vider and diabetes disease outcomes,
as well as the type and duration of
assistance needed to eliminate the
transition-related deterioration in gly-
cemic control.
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